Answers are grounded in this paper and cite their sources.
The use of antibacterial and antimycotic therapy in children with AD complicated by secondary bacterial and fungal infections, which led to an overall therapeutic effect in 85.3% of cases, a 4-fold reduction in the frequency of exacerbations and 3.5-fold remission, allows stopping infection and skin inflammation.
No takes yet. Share an insight, caveat, or question.
B. et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: